Quick Search
-
Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?
Review|Published on: 30 May 2021 -
Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy
Review|Published on: 11 May 2021
Review Articles See more
-
The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas
Published on: 19 Mar 2021 -
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
Published on: 14 Apr 2021
-
Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
Published on: 19 Mar 2021 -
Key genes and drug delivery systems to improve the efficiency of chemotherapy
Published on: 19 Mar 2021 -
P53-regulated autophagy and its impact on drug resistance and cell fate
Published on: 19 Mar 2021 -
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Published on: 19 Mar 2021
Original Articles See more
Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro
-
-
Evaluation of the reducing potential of PSMA-containing endosomes by FRET imaging
Published on: 19 Mar 2021 -
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
Published on: 19 Mar 2021 -
A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
Published on: 19 Mar 2021
-
EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer
Published on: 5 Dec 2020 -
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
Published on: 19 Mar 2021
-
MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression
Published on: 25 Apr 2020
-
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel
Published on: 17 Apr 2020
Other Types of Articles See more
-
Overcoming drug resistance in glioblastoma: new options in sight?
Editorial|Published on: 13 Jan 2021 -
Application of liquid biopsy for prognostic status of cancers and drug response
Editorial|Published on: 3 Nov 2020 -
Can HIPEC be used against platinum-resistance and for inducing sensitivity to PARP inhibitors in ovarian cancer?
Commentary|Published on: 10 Jul 2020
Most Cited Papers In Last Two Years See more
-
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
Review|Published on: 19 Dec 2019 -
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Review|Published on: 19 Sep 2019
-
The role of exosomal long non-coding RNAs in cancer drug resistance
Review|Published on: 19 Dec 2019 -
Cancer stem cells in neuroblastoma therapy resistance
Review|Published on: 19 Dec 2019 -
New insights into acquired endocrine resistance of breast cancer
Review|Published on: 19 Jun 2019
Ongoing Special Issues See more
-
Topic: Resistance to Anti-Angiogenic Therapy in Cancer
Submission Deadline: 30 Jun 2022
Published articles: 0
-
Topic: Tumor Microenvironment and Drug Resistance
Submission Deadline: 31 Dec 2021
Published articles: 0
-
Topic: DNA Repair & Metabolism and Cancer Drug Resistance
Submission Deadline: 31 Dec 2021
Published articles: 0
-
-
Topic: Cell Cycle-based Therapies to Overcome Chemoresistance
Submission Deadline: 31 Dec 2021
Published articles: 0
-
Topic: Molecular Mechanisms of Targeted Therapy Resistance in Breast Cancers
Submission Deadline: 31 Oct 2021
Published articles: 0
-
Topic: Research Progress on Drug Resistance in Acute Myeloid Leukemia
Submission Deadline: 30 Oct 2021
Published articles: 0
-
Topic: Drug Resistance in Metastatic Castration-Resistant Prostate Cancer
Submission Deadline: 1 Oct 2021
Published articles: 0
-
-
Topic: Circulating Biomarkers: Prospects in Cancer Drug Resistance
Submission Deadline: 20 Sep 2021
Published articles: 0
-
-
Topic: Advanced Research of Drug Resistance in Soft Tissue and Bone Sarcoma
Submission Deadline: 31 Aug 2021
Published articles: 0
-
Topic: The Role of the Microbiome in Drug Resistance
Submission Deadline: 31 Aug 2021
Published articles: 0
-
Topic: Drug Targets and Resistance Mechanisms in Multiple Myeloma
Submission Deadline: 31 Jul 2021
Published articles: 0
-
Topic: Drug Resistance and New Therapies in Colorectal Cancer
Submission Deadline: 30 Jun 2021
Published articles: 0
-
Topic: Roles of Signaling Pathways in Drug Resistance
Submission Deadline: 31 May 2021
Published articles: 1
-
Topic: Research Progress on Drug Resistance in Lymphomas
Submission Deadline: 30 Apr 2021
Published articles: 1
-
Topic: Mechanism and Detection of Acquired Drug Resistance in Cancer therapy
Submission Deadline: 31 Mar 2021
Published articles: 1
-
Topic: Recent advances in Tumor-Targeting Chemotherapy Drugs
Submission Deadline: 31 Jan 2021
Published articles: 3
-
Topic: ABC Transporters in Multidrug-Resistant Cancer
Submission Deadline: 20 Nov 2020
Published articles: 5
Special Issue Ebooks See more
.jpg)
About The Journal
-
ISSN
2578-532X (Online)
Publisher
OAE Publishing Inc.
Article Processing Charge
OAE Publishing Inc. undertakes Article Processing Charge for authors
-
Editor-in-Chief
Godefridus J. PetersPublishing Model
Gold Open Access
Copyright
Copyright is retained by authors
-
Publication Frequency
Quarterly
Journal Data Analysis
Total publications: 217
Total article views: 617,378
Total article downloads: 87,489
Open Archives
-
Portico
All published articles will be preserved here permanently:
https://www.portico.org/
